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ABSTRACT
Fanconi anemia (FA) is a rare genetic disease characterized by an increased risk for
bone marrow failure, leukemia, and premature cancers (Alter et al., 2018). The FA
pathway is involved in the repair of DNA damage such as stalled replication forks and
DNA interstrand crosslinks (ICL) (Feng et al., 2019; Schlacher et al., 2012). It has
been previously seen that under conditions of replication stress, FANCD2, a key
protein in the FA pathway, binds to and traverses large actively transcribed genes
(Okamoto et al., 2018). Using U2OS 3xFLAG cells we seek to answer the question of
why FANCD2 is binding to these genes and if by doing so is it acting as a regulator of
transcription? To answer this question, we used a candidate gene approach and chose
WWOX and SOX5 and observed if under conditions of aphidicolin (APH), there were
changes in their protein and transcript levels. We also observed if the absence of
FANCD2 would affect their protein and transcript levels. In this study, it was found
that under conditions of replication stress there was little change in both the protein
and transcript levels of SOX5 and WWOX. Interestingly, the analysis of an RNA
sequencing experiment brought to light the potential for FANCD2 to be involved in
neuronal development as it was found that there were significant differences in
normalized read counts in a subset of neuronal genes in the absence of FANCD2.
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CHAPTER 1

INTRODUCTION

Fanconi anemia (FA) is a rare genetic disorder that can lead to bone marrow failure,
leukemia, and premature cancers (Alter et al., 2018). The median age of onset of FA is
seven years but patients may exhibit symptomatic and asymptomatic disease from
birth to the age of fifty (Fiesco-Roa et al., 2019). Biallelic mutations in one of the
twenty-three FA genes that encode for proteins can lead to FA diagnosis (Fiesco-Roa
et al., 2019). FA results from biallelic mutations in any one of the following genes:
FANCA, FANCB, FANCC, BRCA2 (FANCD1), FANCD2, FANCE, FANCF, FANCG,
FANCI, BRIP1 (FANCJ), FANCL, FANCM, PALB2 (FANCN), RAD51C (FANCO),
SLX4 (FANCP), ERCC4 (FANCQ), RAD51 (FANCR), BRCA1 (FANCS), UBE2T
(FANCT), XRCC2 (FANCU), MAD2L2 (FANCV), RFWD3 (FANCW) (Milletti et al.,
2020). Patients with FA have an increased chance of developing acute myelogenous
leukemia and squamous cell carcinomas of the head and neck in comparison to the
non-FA population (Scheckenback et al., 2012; Fiesco-Roa et al., 2019). Clinical
characteristics of patients with FA include physical abnormalities such as short stature,
microcephaly, and abnormal skin pigmentation as well as an overall increased chance
of developing cancers (Hays et al., 2014). It is important to note that FA patients
should be further subtyped as there is clinical variability amongst the subtypes.
The FA genes are autosomal recessive apart from FANCB which is X-linked,
and FANCR which is autosomal dominant. They are involved in the DNA damage
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repair pathway which is associated with the mending of DNA interstrand crosslinks
(ICL) and stabilization of stalled replication forks (Fig. 1) (Feng et al., 2019;
Schlacher et al., 2012). The elimination of DNA damage is necessary for the
maintenance of genomic integrity. Inefficient repair of DNA damage can lead to
genomic instability increasing the likelihood of cancer commencement and
development (Niraj et al., 2019). The common diagnostic test for establishing if
someone has FA is by determining if there is cellular hypersensitivity to DNA
interstrand crosslinking agents (ICLs) such as mitomycin C (MMC). The exposure of
FA cells to this agent results in increased levels of chromosomal aberrations, including
chromosomal breaks and radial formations, as well as an increase in cell cycle arrest at
the G2/M phase (Kee & D’Andrea, 2012).
The FA protein network can be further divided into groups based on
commonalities in function. FANCA, FANCB, FANCC, FANCE, FANCF, FANCG,
FANCL, and FANCM function as the FA core complex and together with the E2
ubiquitin-conjugating enzyme FANCT/UBE2T, monoubiquitinate FANCD2 and
FANCI. FANCL, FANCB, and FAAP100 can also form a sub-catalytic complex that
is able to support low levels of monoubiquitination, while FANCA-FANCG-FAAP20
and FANCC-FANCE-FANCF provide support for the chromatin and DNA damage
associated with the catalytic module (Huang et al., 2014). Mutations in any one of the
eight proteins in the core complex results in loss of function in the FANCD2/FANCI
monoubiquitination (Kee & D’Andrea, 2012). FANCI and FANCD2 are paralogs and
when monoubiquitinated, form a heterodimer that will be referred to as ID2 (Joo et al.,
2011).
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Figure 1. Identification and coordination of FA pathway in ICL
repair. a,b. Replication forks stall at DNA ICLs and recognized by
FANCM-FAAP24-MHF1-MFH2 (FAAPs) or UHRF1. Helicase
removed by BRCA1 allowing one of the replication forks to converge
on the ICL. c. FANCM further assists in the initiation of the ATR-kinase
dependent checkpoint. d. FA core complex monoubiquitinates FANCIFANCD2 (ID2) complex. e. FANCD2 recruit’s endonuclease to ICL site
to induce DSB to further be repaired by homologous recombination
(HR) (adapted from Niraj et al., 2019).
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Recently, Tan et al., 2020 discovered that the monoubiquitination of ID2
promotes protein:protein interaction and helps to stabilize the ID2 heterodimer onto
the double stranded DNA (dsDNA). This clamping action has also been seen to only
require the monoubiquitination of FANCD2 but not the dimer (Tan et al., 2020). The
monoubiquitination of ID2 promotes the assembly of foci at sites of DNA damage in
chromatin to further facilitate DNA repair and protect the genome. FANCI along with
the core complex are required to produce FANCD2 foci that mark locations of DNA
double-stranded breaks (DSBs), stalled replication forks, and R-loops in the nucleus in
order to protect nascent DNA from degradation by nucleases (Taniguchi et al., 2002;
Schwab et al., 2015). Following the exposure of DNA to damaging agents, and during
S-phase of the cell cycle, the core complex will monoubiquitinate FANCD2 at lysine
561 to signal the activation and translocation to nuclear foci (Garcia-Higuera et al.,
2001).
Post monoubiquitination, there is a recruitment of effectors that cleave the
DNA including FANCQ (XPF) and FANCP (SLX4) (Y. Kim et al., 2011; Stoepker et
al., 2011). FANCM-FAAP24-MHF also form a complex which acts upstream of the
FA pathway to detect DNA damage as well as initiate signal transduction pathways to
promote the monoubiquitination (Nepal et al., 2017). The monoubiquitination leads
the BRCA2 protein into chromatin complexes to facilitate the assembly of DNA
damage inducible RAD51 nuclear foci (Taniguchi et al., 2002; Schwab et al., 2015).
FANCD2 will also oversee the coordination of ICL incision by SLX4-XPF or FAN1
nuclease leading to repair by homologous recombination (H. Kim & D’Andrea, 2012).
While it has been established that the monoubiquitination of FANCD2 is essential for
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some DNA damage inducer resistance, how FANCD2 does this as well as responds to
DNA replication stress is not fully understood.
The replication of the human genome is an intricate process that requires the
organized activation and maintenance of replication forks ensuing from many sites of
origins of replication during S-phase (Schwab et al., 2015). Precise DNA replication
requires numerous factors, including proteins of the FA pathway. The accurate
duplication of chromosomes, followed by their even segregation during mitosis is
essential for genome stability (Mankouri et al., 2013). Errors that can occur during
replication can impact the precise copying of chromosomes and segregation during
mitosis. Replication stress is therefore, one of the main sources of genome instability.
Sources of replication stress result from both endogenous as well as exogenous
sources and can act either locally or globally. Sources can be categorized into
alternations of origins firing, impediments to fork progression, conflicts between the
DNA replication and transcription machineries, and DNA replication in unfit
metabolic conditions (Magdalou et al., 2014).
Collapsed replication forks are a frequent contributor to spontaneous
recombination events and genomic instability, both of which are hallmarks of cancer.
DNA replication originates at thousands of individual replication origins that form
bidirectional replication forks. Prior to S-phase, every origin is prepped by
combinations of replication initiation proteins to ready the chromatin for replication
(Barlow et al., 2013). After commencing, cells need to achieve balance, accuracy,
speed, as well as the utilization and administration of necessary resources for example
nucleotides and replication factors to complete replication in a timely manner.
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Therefore, eukaryotic cells initiate replication origins intermittently, dividing them
into early replicating and late-replicating origins (Zeman & Cimprich., 2014).
DNA replication must also work through parts of the genome that are
considered as more difficult to replicate because of an increased probability of breaks
and gaps. Regions of the genome known as common fragile sites (CFSs) are more
prone to breaks and gaps on metaphase chromosomes likely because of an increase of
stalled replication forks at these regions (Debatisse et al., 2012). These regions require
the replication fork to progress through CFSs, which causes a reliance on fork-restart
mechanisms (Magdalou et al., 2014). When the DNA polymerase has stalled, helicases
are continuing to unwind DNA resulting in an accumulation of single stranded DNA
(ssDNA) at stalled forks. ssDNA is more unstable and more prone to be acted upon by
nucleases (Byun et al., 2005).
During replication stress, regions containing CFSs have paused replication
forks and consequently the forks are either at a standstill or moving slower as they
move from flanking regions through CFSs to complete replication. This results in the
inevitable collision of replication and transcription machineries intensifying genome
instability (Debatisse et al., 2012). One result of this collision is the formation of Rloops, which are DNA: RNA hybrids, that result from the nascent transcript
reannealing to the corresponding template DNA strand causing the non-template
strand to be displaced as ssDNA (Hamperl & Cimprich, 2016). These hybrids can lead
to DNA damage because of the exposure of the ssDNA (Sollier & Cimprich, 2015).
Previous studies show that the transcription of large genes can require more than one
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cell cycle, consequentially resulting in replication-transcription collisions resulting in
potential R-loop formations (Hamperl & Cimprich, 2016).
Replication-transcription conflicts are often inevitable as there are many large
genes in the genome requiring start-restart replication as well as more than one cell
cycle for transcription (Helmrich et al., 2011). Conflicts are unavoidable in the longer
human genes because these genes often overlap with CFSs resulting in longer times
for transcription. Genes overlapping with CFSs are also replicated late in S-phase and
are hotspots for chromosome instability (Le Tallec et al., 2014). This frequent
association seen between large genes and transcriptional fragility, suggests a
functional relationship, however the mechanisms underlying this association are not
fully understood (Le Tallec et al., 2014) Collisions of the two systems can as
previously stated result in R-loop formations but can also result from cis structural
features such as DNA supercoiling, CFSs, and G-quadruplexes (Fig. 2) (García-Muse
& Aguilera, 2016).
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Figure 2. The FA pathway and replication stress. While undergoing
replication stress, the ATR checkpoint kinase is activated resulting in the
monoubiquitination of the FANCD2-FANCI complex by the FA core E3
ligase complex. This causes the replication machinery to be put under
pressure and collide with concurrent transcription complex causing
transcripts to enter the DNA helix and create R-loops. FANCD2 is
recruited to sites of R-loops however, how it is recruited is still unknown
(adapted from Okamoto et al., 2019).
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As DNA replication continues, it exposes ssDNA because of lagging strand
synthesis. These ssDNA are more prone to fold into G-quadruplexes and impede
replication fork progression. G-quadruplexes form due to the repetitive nature of the
genome and can result in genomic instability (Hänsel-Hertsch et al., 2017). They are
non-canonical DNA secondary structures that form because of the interactions of
guanines in G-rich sequences where the nucleotides have interacted by Hoogsteen
hydrogen bond that have been stabilized by a cation (Maffia et al., 2020).
A frequent hindrance of replication is caused when the replication fork
encounters CFSs. These regions have been seen to undergo chromosomal
rearrangements in tumors but the correlation between their role in cancer and
implementation in replication has only recently been uncovered (Maffia et al., 2020).
Studies have seen that these regions in the genome are sensitive to replication stress
and the treatment of cells with aphidicolin, a DNA polymerase inhibitor, can cause
breaks in metaphase chromosomes (Glover et al., 2017; Helmrich et al., 2011). When
replication forks are confronted with obstacles during S phase, normally dormant
replication origins are fired to prevent or rescue the instability. These CFS regions can
be large with some being greater than 1 Mb in length as seen in a recent study
identifying FANCD2 accumulating at large transcriptionally active genes (Okamoto et
al., 2018). The Okamoto study found that FANCD2 preferentially bound to sites that
were enriched near the center of the genic region of the large genes. Large genes can
have a greater distance between dormant origins, increasing the likelihood of
replication stress occurring. When replication stress is encountered at CFSs, because
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of the short supply of origins, the ability to activate this rescue mechanism is lost
(Shima & Pederson, 2017).
Recent studies have investigated if there is a connection between FANCD2 and
CFSs. One study has found that FANCD2 has been shown to reposition to large genes
that comprise CFSs after replication stress (Fernandes et al., 2021). It has also been
seen that FANCD2 forms foci at CFSs during mitosis, marking these areas as
damaged (Chan et al., 2009). As a result of the FA pathway involvement in the
coordination of replication and transcription by preventing or mending R-loops, a
connection forms between the failure to resolve R-loops, CFS replication, and the
genomic instability commonly seen in FA patients. In addition, a connection can be
formed as FANCD2 has been seen to promote CFS replication by the regulation of Rloop formation (Okamoto et al., 2019). It has also been previously seen that FANCD2
may help promote the replication of CFSs (Madireddy et al., 2016).
Further recent discoveries involving FANCD2 include that FANCD2 has been
seen to accumulate on large actively transcribed genes when under conditions of
replication stress (Okamoto et al., 2018). A genome-wide chromatin localization of
FANCD2 using chromatin immunoprecipitation sequencing (ChIP-seq) analysis was
used to identify the binding footprints of FANCD2. This study found that FANCD2
accumulates in the central region of large actively transcribed genes with some of the
genes overlapping with known CFSs in cells that had been cultured in the presence of
aphidicolin (Okamoto et al., 2018). This study also assembled a list of the top thirty
genes of a total of 120, that FANCD2 was found to bind to under conditions of
replication stress (Table 1). However, what this study did not find was why is
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FANCD2 binding to these regions, and if by doing so it is preventing the transcription
in these areas undergoing replication stress.
It has also been recently discovered that many of these large genes are prone to
copy number variation (CNV) (Wilson et al., 2015). This is a type of mutation where
the gene copy number can vary under certain conditions. Under replication stress,
there could be a deletion of one allele and a triplication of the other allele causing the
normal number of alleles to increase from two to three. At a locus that is more prone
to CNV, there can be considerable variability in copy number and consequently in the
levels of transcription of that gene (Wilson et al., 2015).
While there have been many studies of FANCD2 acting as part of the damage
response, it has only recently come to light that this protein may have another function
of acting as a transcriptional repressor for large actively transcribed genes that are
undergoing replication stress. FANCD2 has been seen to bind to large
transcriptionally active genes and that because of its role in DNA repair, it is binding
to these regions because they are more susceptible to DNA damage. The question
remains of what is FANCD2 doing when it binds to these large actively transcribed
genes? Is it acting as a protector of the genome by blocking susceptible genes from
being transcribed and causing DNA damage?
In this study, we used a candidate gene approach to test the hypothesis: if there
are changes in gene expression at the sites that FANCD2 is found to bind to, then is
FANCD2 impacting gene expression by binding to these regions? We focus on SOX5
and WWOX in U2OS 3xFLAG cells to answer this question as these two genes encode
for proteins found in the top ten of the top thirty genes list and were shown to have
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broad FANCD2 peaks in the ChIP-seq data (Figs. 3 & 4). Aphidicolin, as previously
stated is a DNA polymerase inhibitor and frequent inducer of replication stress.
Through the utilization of aphidicolin as the replication stress inducer, we used
immunoblotting as well as quantitative-PCR (qPCR) to analyze both the protein and
transcript levels of SOX5 and WWOX. These two genes were chosen as SOX5, is a
transcription factor involved in breast cancer regulation, and WWOX, a member of
short-chain dehydrogenases and is found to span the common fragile site FRA16D
(Driouch et al., 2002; Pei et al., 2014). They were also chosen because both proteins
are intracellular making them good targets for immunoblotting using whole cell
lysates. We first determined if there was a change in the protein and transcript levels
under aphidicolin conditions and hypothesized that when FANCD2 is present and
under conditions of replication stress, the amount of protein and transcript levels will
decrease. We then used an siRNA to knock down FANCD2, aphidicolin as our
replication stress inducer, and analyzed the consequences this had on both the protein
and transcript levels and hypothesized that the levels will then increase in the absence
of FANCD2.
We further analyzed the role FANCD2 may play under replication stress
conditions by using ACHT hTERT cells both with and without FANCD2 and both
with and without aphidicolin treatment for RNA sequencing. ACHT hTERT cells are a
telomerase immortalized primary fibroblast patient cell line. ACHT hTERT FANCG
(FANCD2 -/-) lack FANCD2 and ACHT hTERT FANCD2 have FANCD2
complemented back into the line (ACHT hTERT +FANCD2). A patient cell line was
used instead of U2OS 3xFLAG cells to observe a more realistic cell line that could be
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more similar to an FA patient with a mutation in FANCD2 as opposed to a
transformed cell line (U2OS 3xFLAG). This experiment allowed us to view the
overall transcriptome to reveal not only if there are a greater number of genes affected
by the presence or absence of FANCD2 but also if there is a pattern to the type of gene
affected.
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Table 1. Okamoto et al., 2018 ChIP-seq top 30 hits of FANCD2 overlap. List of
top 30 genes that FANCD2 was found to bind to, the chromosome location of the
gene, if the location coincides with a known CFS, and the number of reads under
aphidicolin (APH) conditions.
Top hits
order
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30

Chromosome
location
10q23
16q23
16q23
9p21
7p22
11q14
3p14
3q11
3p26
12p12
10q11
21p11
7q31
21p11
5p14
1p31
5p15
8q24.3
20p12
4p15
1p36
11q13
7q11
7q11
13q33
4q35
9p32
22q13
Xq22
2q22

Gene

CFS

NRG3*
WWOX
CDH13*
LINGO2*
SDK1*
DLG2*
FHIT*
EPHA6*
CNTN4*
SOX5
PRKG1
miR-3648
IMMP2L*
miR-3687
CDH12*
NEGR1*
CTNND2*
TRAPPC9*
MACROD2*
MAGI2*
AUTS2*
FAM155A
FRG2
ASTN2*
DIAPH2
THSD7B

FRA16D
FRA9C
FRA7B
FRA11F
FRA3B
FRA10C
FRA7K
FRA1L
FRA8D
FRA4D
FRA1A
FRA11H
FRA7J
FRA22A
-

Number of
reads
8608
7929
4704
3832
3395
3302
3082
3074
2906
2241
2091
2002
1937
1929
1800
1392
1072
1001
891
860
797
765
636
616
497
401
380
346
339
322

Genes with (*) are related with autism, neurodevelopmental or psychiatric disorders.
The number of ChIP-seq reads found in a gene or in a region that consist of a
combined gene of CFS. SOX5 and WWOX have been highlighted.
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Figure 3. FANCD2 displays broad peak over WWOX. ChIP-seq data
from Okamoto et al., 2018 depicting FANCD2 accumulating in broad
peaks over WWOX. U2OS 3xFLAG cells were treated with 0.4 µM
aphidicolin (APH) for 24 hours. Anti-FLAG ChIP-seq reads depicting
the WWOX gene region under no treatment (NT; yellow) or APH
(orange) with peaks shown in blue. Image made using Integrated
Genomics Viewer (IGV). Input samples are those have been crosslinked
but not immunoprecipitated and are used as the control.
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Ok_Input_NT
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Figure 4. FANCD2 displays broad peak over SOX5. ChIP-seq data
from Okamoto et al., 2018 depicting FANCD2 accumulating in broad
peaks over SOX5. U2OS 3xFLAG cells were treated with 0.4 µM
aphidicolin (APH) for 24 hours. Anti-FLAG ChIP-seq reads depicting
the SOX5 gene region under no treatment (NT; yellow) or APH (orange)
with peaks shown in blue. Image made using Integrated Genomics
Viewer (IGV). Input samples are those have been crosslinked but not
immunoprecipitated and are used as the control.
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CHAPTER 2

METHODOLOGY

Cell Culture
We received U2OS 3xFLAG cells created by Okamoto et al., 2018 that stably
integrated a 3xFLAG on the 3’ end of the FANCD2 coding sequence. U2OS 3xFLAG
cells are an osteosarcoma line and were grown in Dulbecco modified Eagle medium
(DMEM) supplemented with 10% (vol/vol) fetal bovine serum, 1% (vol/vol Lglutamine, and 1% (vol/vol) penicillin-streptomycin.
ACHT hTERT FANCD2 and ACHT hTERT FANCG (FANCD2-/-) cells
received from Kalb et al., 2007, were grown in Dulbecco modified Eagle medium
(DMEM) supplemented with 18% fetal bovine serum (vol/vol), 1% (vol/vol Lglutamine, and 1% (vol/vol) penicillin-streptomycin. ACHT hTERT cells are human
FA-D2 (FANCD2-/-) telomerase-immortalized skin fibroblast cells with one cell line
having FANCD2 complemented into the cell. Mutations include: Allele 1 c.2444G>A
(exon 26), r.2444G>A, p(R815Q), and Allele 2 c.2715+G>A,
c.2715+1G>A (IVS28+1G>A), r.2715_2716ins27 (aberrant splicing), and
p.(E906Lfs *4) (Kalb et al., 2007).

Immunoblotting
For immunoblotting analysis, cells were washed in phosphate-buffered saline (PBS)
and lysed in 2% w/v SDS, 50 mM Tris-HCl, 10 mM EDTA followed by sonication for
10 s at 10% amplitude. Proteins were resolved on NuPage 3-8% w/v Tris-Acetate or 417

12% w/v Bis-Tris gels (Invitrogen) and transferred to polyvinylidene difluoride
(PVDF) membranes. Antibodies and concentrations used are in Table 5.

Replication Stress assay
U2OS 3xFLAG cells were plated at 1 x 106 cells/mL and grown for 24 hours in 10
cm2 dishes in a total of 8 mL DMEM media supplemented with 10% FBS, 1% (vol/vol
L-glutamine,

and 1% (vol/vol) penicillin-streptomycin. Cells were then treated with

0.4 µM aphidicolin (APH) for 24 or 48 hours. One set of cells were then released from
APH treatment and allowed to grow for an additional 24 hours. Cells were harvested
24 hours after APH treatment, 48 hours after APH treatment, and 24 hours after
release from APH treatment. ACHT hTERT FANCD2 and ACHT hTERT FANCG
cells were also subjected to same experimental conditions. Cells were trypsinized
using 0.05 % trypsin for 4 minutes. Media was then added to neutralize the trypsin and
cells were spun down for 4 minutes to pellet in 15 mL centrifuge tubes. Media was
then aspirated and cells were pelleted by centrifugation and resuspended in PBS

siRNA
U2OS 3xFLAG cells were plated at 1.75 x 105 cells per well in a 6 well plate and the
following day treated with a 20 nM FANCD2 siRNA (target sequence:
AACAGCCATGGATACACTTGA) or an siControl, and lipofectamine 2000 (Thermo
Fisher) (Howlett et al., 2005). siControl is a random sequence that does not target a
specific gene. siFANCD2 or siControl was left on for 24 hours, removed and allowed
to recover for 24 hours. Cells were then incubated in the absence or presence of 0.4
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μM APH for 24 hours, 48 hours, or 24 hours plus 24 hours of release to induce
replication stress. Cells were harvested 24 hours or 48 hours after APH treatment. The
control for this experiment was a no treatment siControl in the presence and absence
of APH. The siControl is used as it is an siRNA but does not target a specific gene.

RNA Isolation
U2OS 3xFLAG cells were grown in 10 cm2 dishes and treated using the replication
stress assay as stated above. Cells were trypsinized using 0.05 % trypsin for 4 minutes.
Media was then added to neutralize the trypsin and cells were spun down for 4
minutes to pellet in 15 mL centrifuge tubes. Media was then aspirated and cells were
pelleted by centrifugation and resuspended in PBS. Using the PureLink RNA Mini Kit
(ThermoFisher) RNA was isolated, 80 µL/sample of a ~3 U/µL DNase treatment
(ThermoFisher) was applied to the column provided in the PureLink RNA Mini Kit,
and RNA was quantified using Nanodrop 2000 (ThermoFisher).

cDNA Synthesis
RNA was converted into single-stranded cDNA using the High-Capacity Reverse
Transcription Kit (ThermoFisher). 1 µg of RNA was used from each sample. cDNA
quantification was done using Nanodrop 2000 (ThermoFisher). 500 ng of cDNA was
used in quantitative real-time PCR (qPCR).
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qPCR
Abundance of SOX5 and WWOX transcripts were determined relative to GAPDH
transcript abundance by qPCR. 5 µL PowerUp SYBR Green master mix
(ThermoFisher) was used along with 4µL of 1.25 µM of primers designed by
Integrated DNA Technologies (IDT) were used and Origene Technologies. Samples
were run on the Roche LightCycler 480 at the URI Genomics and Sequencing Center.
1 µL of a 500 ng stock of cDNA was used in the reaction. Data were analyzed via the
2−ΔΔCT calculation method. Each reaction was run with initial denaturation at 95 ºC for
5 minutes, followed by 45 cycles of denaturation at 95 ºC for 15 seconds, annealing at
66 ºC for 15 seconds, and an extension of 1 minutes at 72 ºC. After completion of the
last cycle, a melt curve analysis was performed according to the machine’s preset Step
and Hold protocol (95 ºC for 5 seconds; 65 ºC for 1 minute; temperature ramp
increment of 0.3 ºC up to 95 ºC).
Primer Efficiency
Primer efficiency qPCR was performed using 1500 ng, 150 ng, 15 ng, 1.5 ng, and 0.15 ng
cDNA for GAPDH, WWOX, SOX5, and FANCD2. The same protocol as used for qPCR
was used for the efficiency test with 1 µL of cDNA, 5 µL of PowerUp SYBR Green
master mix, and 4 µL of the 1.25 µM stock primer. Primer efficiency was run for 2
different sets of WWOX primers (WWOX 1 and WWOX 2), 2 different sets of SOX5
primers (SOX5 1 and SOX5 2), and 3 different sets of FANCD2 primers (FANCD2 1,
FANCD2 2, and FANCD2 3).
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Primer Gradient
Primer gradient PCR was performed using temperatures of 54.2, 55.2, 57.8, 59.5, 62.7,
and 64.1 °C as well as 59.4, 62.4, 64.3, 66.2, 68.1, and 71 °C. Quantities of cDNA

tested include 50 ng, 100 ng, 200 ng, 500 ng, and 1µg. Initial PCR reaction was the
same as used for qPCR with 1 µL of the stock cDNA, 5 µL of PowerUp SYBR Green
master mix, and 4 µL of the 1.25 µM stock primer. The PCR gradient was carried out on
an Eppendorf vapo.protect Thermocycler with an initial denaturation of 94 ºC for 2
minutes, followed by 40 cycles of denaturation for 5 seconds at 95 ºC, annealing at
gradient temperatures (59.4, 62.4, 64.3, 66.2, 68.1, 71.0 °C), and an extension at 72 °C

for 10 seconds.
PCR products were tested on a 2% agarose gel using 1x TBST and 10 µL SYBR
SAFE DNA gel stain. 2 µL of 6x gel loading dye was added to the 10 µL reaction and the
total 12 µL was loaded onto the gel. Agarose gel was run at 100 V for 50 minutes on a
PowerEase 90W by Life Technologies. Gel was imaged using the Bio-Rad imager in the
Howlett Lab.

RNA-seq Analysis
ACHT hTERT FANCD2 and ACHT hTERT FANCG (FANCD2-/-) cells were
seeded, and the following day treated with 0.4 µM APH for 24 hours, 48 hours, and a
no treatment sample in quadruplet. Cells were trypsinized using 0.25 % trypsin for 8
minutes. Media was then added to neutralize the trypsin and cells were spun down for
4 minutes to pellet in 15 mL centrifuge tubes. An ice-cold PBS wash was then applied,
and cells were transferred to a 1.5 mL microcentrifuge tube where they were again
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spun down in a microcentrifuge set to 4°C for 4 minutes. PBS was aspirated and cells
were flash frozen using liquid nitrogen.
24 samples were sent to Genewiz in South Plainfield, NJ, USA. RNA library
preparation with polyA selection and HiSeq Sequencing RNA library preparations was
also completed at Genewiz. RNA samples were quantified using Qubit 2.0
Fluorometer (Life Technologies, Carlsbad, CA, USA) and RNA integrity was checked
using Agilent TapeStation 4200 (Agilent Technologies, Palo Alto, CA, USA). RNA
sequencing libraries were then prepared using NEBNext Ultra II RNA Library Prep kit
for Illumina using the manufacturer’s instructions (NEB, Ipswich, MA, USA).
mRNAs were then initially enriched with Oligod(T) beads, and the enriched mRNAs
were fragmented for 15 minutes at 94 °C. First and second strand cDNA was then
subsequently synthesized, and the cDNA fragments were end repaired and adenylated
at the 3’ ends. Universal adapters were ligated to cDNA fragments and followed with
an index addition and library enrichment by PCR with limited cycles. The sequencing
library was then validated on the Agilent TapeStation (Agilent Technologies, Palo
Alto, CA, USA), and quantified by using Qubit 2.0 Fluorometer (Invitrogen, Carlsbad,
CA) as well as by quantitative PCR (KAPA Biosystems, Wilmington, MA, USA). The
sequencing libraries were then clustered on a single lane of a flowcell and following
clustering, the flowcell was loaded onto the Illumina HiSeq 4000 instrument according
to manufacturer’s instructions. Samples were sequenced using a 2x150bp Paired End
configuration at 60 million reads per sample. Image analysis and base calling were
conducted using the HiSeq Control Software (HCS). The raw sequence data (.bcl files)
were generated from the Illumnia HiSeq and converted into fastq files. They were then
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de-multiplexed using Illumina’s bcl2fastq 2.17 software. One mismatch was allowed
for index sequence identification.

Bioinformatics Workflow
To analyze the quality of the raw data, the sequence reads were trimmed to
remove possible adapter sequences as well as nucleotides with poor quality using
Trimmomatic v.0.36. The quality threshold parameters under Trimmomatic were set at
15 for the sliding window size of 4. Data quality ³ 80% of bases ³ Q30 were kept. The
trimmed reads were then mapped to the most recent Homo sapiens reference genome
that is available on ENSEMBL using the STAR aligner v.2.5.2b. STAR aligner is a
splice aligner that can detect splice junctions and will incorporate them to help align
the entire read sequences. BAM files were then generated, and unique gene hit counts
were calculated by using FeatureCounts from the Subread package v.1.5.2. Only
unique reads that fell within exon regions were counted. After the extraction of gene
hit counts, the gene hit counts table was used for downstream differential expression
analysis. DESeq2 was then used to compare gene expression between the groups of
samples. The Wald test was then used to generate p-values and Log2foldchanges.
Genes that had adjusted p-values were called as differentially expressed genes for each
of the comparisons and a gene ontology analysis was performed on the statistically
significant set of genes using the software GeneSCF. The goa_human GO list was
then used to cluster the set of genes.
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Statistical Analysis
To determine significance, either a single-factor ANOVA or two-factor ANOVA was
used to test and post-hoc analysis was performed if significance was found. Student’s
two-tailed paired t-test was also performed. P-value was determined using the
Bonferroni correction of the p-value for each test (0.05) divided by the number of tests
performed.
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Table 2. Cell culture reagents used and catalog numbers. The following table
includes a list of cell culture reagents and the company that they were purchased from.
Product Name

Source

Catalog Number

DMEM 1x

ThermoFisher

11965118

L-glutamine

ThermoFisher

25030081

Penicillin-streptomycin

ThermoFisher

15070063

PBS

ThermoFisher

10010049

0.05% Trypsin

ThermoFisher

25300054

0.25% Trypsin

ThermoFisher

25200056

FBS

ThermoFisher

10437028

Lipofectamine 2000

ThermoFisher

11668-027
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Table 3. Immunoblotting reagents used and catalog numbers. The following table
includes the reagents used for immunoblotting and the company they were purchased
from.
Product Name

Source

Catalog Number

3-8% Tris-Acetate Gels

ThermoFisher

EA0378BOX

4-12% Bis-Tris Gels

ThermoFisher

NP0335BOX

NuPage Antioxidant

ThermoFisher

17504044

Clarity

BioRad

1705060
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Table 4. qPCR reagents used and catalog numbers. The following table includes a
list of qPCR reagents and the company that they were purchased from.
Product Name

Source

Catalog Number

PureLink RNA Mini Kit

ThermoFisher

12183018A

SYBR Green

ThermoFisher

4344463

PureLink DNase

ThermoFisher

12185-010

cDNA

ThermoFisher

4368814

Gel Loading Purple Dye

NEB

B7025S

Quick-load Purple 100

NEB

N0551S

ThermoFisher

S33102

Agarose

ThermoFisher

BP160-100

10x TAE

Invitrogen

15558-026

bp DNA Ladder
SYBR Safe DNA gel
stain
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Table 5. Antibodies, catalog numbers, and antibody working dilutions used in
this study. The following table includes the antibodies used for immunoblotting as
well as the company they were purchased from, and the dilution used.
Product Name

Source

Catalog
Number

Dilution used
for ACHT
(µL/mL)

Rabbit

Fisher

NA9341

1:5

Dilution used
for U2OS
3xFLAG
(µL/mL)
1:5

Secondary

Scientific

Mouse

Fisher

NA931

1:5

1:5

Secondary

Scientific

Anti- SOX5

Abcam

ab94396

1:3

1:5

Abcam

137726

1:6

1:8

Anti- Tubulin

Fisher

MS581P0

1:15

1:25

Primary

Scientific

FI17

1:50

1:100

Primary
Antibody
Anti- WWOX
Primary
Antibody

Antibody
Anti-FANCD2

Novus

Primary

Biologicals

Antibody
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Table 6. qPCR primer sequences, melting temperatures (Tm), and sequence
lengths used in this study. The following table includes a list of the primer sequences
used for qPCR as well as the melting temperatures, and sequence lengths.
Gene

Forward Primer

Reverse Primer

Tm

Sequence
Length

OriGene

TCCTCCAGGATG

AAGCCAGCATCGC

WWOX

TTTTGTGCCG

CCAATAGTC

OriGene

CTCGGCAAATGA

ACTGCCAGTTGCT

SOX5

AGGAGCAACTC

GAGTCAGAC

GAPDH

GTCTCCTCTGAC

CCAAATTCGTTGT

TTCAACAGCGAC

CATACCAGGAA

FANCD2

GATGGTGAAGAA GGTCTAATCAGAG

040521

GACGA

TCATC

SOX5 1

ATTGGGATCTCG

GGCCTGGGCTTGT

CTGGAAAG

ACTTATAG

GCCCTAACTGGT

GTCAGCTGATGTC

TCATCCTTAC

CCAACTATT

SOX5 2

WWOX 1

WWOX 2

FANCD2 1

ACGAGTGGCAGG GGTCCAAGTAGGT
AGATTTG

GGTTCTTT

CCTCAGAGTCCC

GCAGAGCTTGGAC

ATCGATTTAC

CTGTTAT

CATCTTCCTCCA

CGTCTTCTCTAGTT
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69, 67

201

66, 62

142

64, 64

113

49, 44

75

61, 58

120

59, 58

103

59, 57

104

60, 57

N/A

60, 58

83

CATTCCCTAC

CAGCCATC

CTGAAGGCCATA

GTAGGGAATGTGG

GAGGAGATTG

AGGAAGATG

FANCD2

CGCCAGTTGGTG

CCATGGCTGTTAC

N-Terminus

ATGGATAA

GGAATGA

FANCD2 3
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60, 60

86

62, 62

91

CHAPTER 3

RESULTS

Analysis of SOX5 and WWOX gene expression following aphidicolin treatment
A previous study by Okamoto et al., 2018 utilized ChIP-seq and determined that under
conditions of DNA replication stress, FANCD2 was found to bind and traverse large
actively transcribed genes. However, it was not determined why FANCD2 was
binding to these genes. To explore if FANCD2 could potentially be acting as a specific
transcriptional repressor of these genes, we used a candidate gene approach to
determine if there were changes in the expression of SOX5 and WWOX genes under
conditions of replication stress. A candidate gene approach allowed us to choose two
genes from the top 30 genes that FANCD2 was found to bind and do an in-depth
analysis of WWOX and SOX5.
Cells were exposed to 0.4 µM APH and samples were run in triplicate and
three biological samples were tested. RNA was purified from each sample and firststrand cDNA was synthesized immediately after RNA isolation. Three separate qPCR
reactions were assembled using the synthesized cDNA, representing three technical
replicates. For each reaction GAPDH was used as the control housekeeping gene.
Cycle threshold (Ct) values were averaged as well as the standard errors for the
analysis. The Ct value is the cycle at which the fluorescence from the amplification
exceeds the background fluorescence with each cycle ideally doubling the target
DNA. The lower the Ct value, the higher the initial copy numbers of the target.
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Ranges of Ct values acceptable for analysis are less than 35 cycles while the
recommended amounts of cDNA added to the reaction range from 5-50 ng of cDNA
depending on the gene of interest as suggested by Thermo Scientific. Once normalized
to GAPDH, the delta Ct values were also averaged for each timepoint. There was a
decrease in gene expression for SOX5 between the no treatment sample and 24 hours
of APH and 48 hours of APH (Fig. 5a). Gene expression then increased in the 24-hour
release sample. While there were changes seen in gene expression, the changes were
not significant. Standard error bars show the amount of variability within the samples
between all replicates (Fig. 5a).
For WWOX, fold change analysis of the gene expression showed that there is a
minor decrease in gene expression in the 24-hour and 48-hour samples in comparison
to the no treatment, and an increase in the release sample but the difference is not
significant (Fig. 5b). Bonferroni correction was applied by dividing 0.05 by the
number of replicates (27).
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Figure 5. Analysis of SOX5 and WWOX gene expression in U2OS
cells incubated in the absence or presence of aphidicolin (APH).
U2OS cells were incubated in the absence (No Treatment) or presence of
0.4 µM APH for 24 hours, 48 hours, or 24 hours plus 24 hours of
release. Error bars represent the standard errors of the mean calculated
from twenty-seven technical replicate measurements from three
independent biological replicate experiments. Statistical significance
was determined using student’s two-tailed paired t-test. *P < 0.001 and
Single-Factor ANOVA. a. SOX5 gene expression. Bonferroni correction
has been applied. b. WWOX gene expression.
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SOX5, WWOX, and GAPDH qPCR primer efficiency analysis
Our results suggested little change in the levels of expression of SOX5 and WWOX
under the conditions tested. Our Ct values for SOX5 and WWOX qPCR analysis also
suggested that our qPCR conditions might not be optimal. Upon consulting with our
colleagues and technical support at Thermo-Scientific, we decided to thoroughly
analyze the efficiency of our qPCR primers using varying amounts of quantified
cDNA input. Each gene had two sets of primers designed that were tested along with
the housekeeping gene, GAPDH. To test the efficiency of the primers, a standard
curve of cDNA was created using quantities of 1500 ng, 150 ng, 15 ng, 1.5 ng, and
0.15 ng of cDNA.
Primers were run using the same protocol as our normal qPCR and standard
curves were created for each primer set with each cDNA quantity run in duplicate.
Analysis included observing the Ct values of the different quantities of cDNA and
how similar amplification curves were between duplicates.
Figure 6 shows the amplification curves for GAPDH, SOX5, and WWOX. The
amplification curves show that the duplicate samples are very consistent and as the
quantity of cDNA decreases, the Ct value at which the amplification curve starts
increases (Fig. 6, 7, 8). The GAPDH standard curve shows that duplicate samples are
very close together and for all five quantities of cDNA, there was amplification. The
Ct values for GAPDH range from 15 at 1500 ng of cDNA to 28 at 0.15 ng of cDNA
(Fig. 6). The WWOX curve again had amplification for all five quantities of cDNA
however, the number of cycles for amplification increased in comparison to the
GAPDH graph. The Ct values for WWOX range from 22 at 1500 ng of cDNA to 35 at
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0.15 ng of cDNA (Fig. 7). For SOX5 there was no amplification for the 0.15 ng cDNA
and the 15-ng amplified late at the 35th cycle the cycle limit for analysis. The Ct values
for SOX5 range from 25 at 1500 ng of cDNA to 35 at 1.5 ng of cDNA (Fig. 8).

35

Figure 6. Analysis of GAPDH primer efficiency using a serial dilution
of cDNA. qPCR was performed using either 1500 ng (blue lines), 150 ng
(red lines), 15 ng (green lines), 1.5 ng (purple lines), or 0.15 ng (grey
lines) with samples being run in duplicate. 1 µL of cDNA was added to 5
µL of SYBR Green master mix, and 4 µL of a 1.25 µM stock primer.
Amplification curves display how similar the duplicate samples are by
how close together the same color curves are. As the amount of input
cDNA decreases, the number of cycles increases.
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Figure 7. Analysis of WWOX2 primer efficiency using a serial
dilution of cDNA. qPCR was performed using either 1500 ng (blue
lines), 150 ng (red lines), 15 ng (green lines), 1.5 ng (purple lines), or
0.15 ng (grey lines) with samples being run in duplicate. 1 µL of cDNA
was added to 5 µL of SYBR Green master mix, and 4 µL of a 1.25 µM
stock primer. Amplification curves display how similar the duplicate
samples are by how close together the same color curves are. As the
amount of input cDNA decreases, the number of cycles increases.
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Figure 8. Analysis of SOX52 primer efficiency using a serial dilution
of cDNA. qPCR was performed using either 1500 ng (blue lines), 150
ng (red lines), 15 ng (green lines), 1.5 ng (purple lines), or 0.15 ng (grey
lines) with samples being run in duplicate. 1 µL of cDNA was added to
5 µL of SYBR Green master mix, and 4 µL of a 1.25 µM stock primer.
Amplification curves display how similar the duplicate samples are by
how close together the same color curves are. As the amount of input
cDNA decreases, the number of cycles increases.
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Optimization of primer annealing temperatures using gradient PCR analysis
To continue our strategy of qPCR analysis optimization, we next performed gradient
PCR analysis to determine the optimal annealing temperatures for our qPCR primers.
Gradient PCR analysis also allowed us to visualize our PCR products to determine if
our primers were amplifying a band of the correct size and determine if any nonspecific products were being generated. A primer gradient was performed utilizing
different concentrations of cDNA, as well as a gradient of temperatures (54.2, 55.2,
57.8, 59.5, 62.7, 64.1°C). The PCR products were run on a 2% agarose gel run for 50
minutes at 100 V. Bands did not appear for SOX5 or WWOX for 50 ng, 100 ng, and
200 ng. Faint bands were seen at 500 ng but not at 1 µg of cDNA at the tested
temperatures signifying that these primers are not optimally amplifying their sequence
targets or indicating that these genes were being expressed at very low levels (Fig. 9).
The GAPDH primers, our positive control and housekeeping gene, showed
amplification at each of the cDNA quantities as well as at all of the tested
temperatures. We also saw amplification for the FANCD2 primers at 100 ng, 200 ng,
500 ng, and 1µg of cDNA at temperatures of 57.8, 59.5, 62.7, and 64.1 °C.
After determining that the WWOX and SOX5 primers tested were not optimally
performing, new primer sets for both genes were ordered and tested. The new primer
sets were tested at 200 ng and 500 ng of cDNA and temperatures of 59.4, 62.4, 64.3,
66.2, 68.1, and 71 °C. Bands were faintly seen at 500 ng for both SOX5 and WWOX at
temperatures of 59.4, 62.4, 64.3, 66.2, 68.1°C (Fig. 10). GAPDH was again used as
the positive control with bands at all temperatures except for 59.4 °C for 500 ng
cDNA. The optimal temperature for all primer sets was determined to be 66 °C with
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500 ng of cDNA as each primer set appeared to have the brightest band at this
concentration and temperature (Fig. 10).
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Figure 9. Primer gradients using different quantities of cDNA and
melting temperatures. Different concentrations of cDNA (50 ng, 100
ng, 200 ng, 500 ng, 1µg), as well as increasing melting temperatures
(54.2, 55.2, 57.8, 59.5, 62.7, 64.1 °C), were run using a gradient PCR to
determine the optimal melting temperature for each primer set. Products
were run on a 2% agarose gel for 50 minutes with a 100 bp ladder and
imaged using BioRad imager. Optimal temperature and cDNA
concentration determined by the brightness of the band.
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Figure 10. Optimal melting temperature determined for new primer
sets. New primer sets for SOX5 and WWOX run on primer gradients using
different quantities of cDNA and melting temperatures. Different
concentrations of cDNA (200 ng, 500 ng), as well as increasing melting
temperatures (59.4, 62.4, 64.3, 66.2, 68.1, 71.0 °C), were run using a
gradient PCR to determine the optimal melting temperature for each
primer set. Products were run on a 2% agarose gel for 50 minutes with a
100 bp ladder and imaged using BioRad imager. Optimal temperature and
cDNA concentration determined by the brightness of the band.
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Analysis of the protein expression of SOX5 following aphidicolin exposure
To study if APH inducing replication stress affected the protein expression of SOX5,
we analyzed via immunoblotting whole cell lysates treated with APH for 24, 48, and a
24-hour release samples (Fig. 11a). It is known that APH induces the
monoubiquitination of FANCD2 and FANCD2 was confirmed to be
monoubiquitinated in this experiment as can be seen in Figure 9b showing the top
band at the 24-, 48-, and 24-hour release samples. Monoubiquitination is confirmed by
the top band in the FANCD2 western blot. L/S ratios which are the ratio between
monoubiquitinated FANCD2 and unubiquitinated FANCD2 were calculated. There is
an increase in the monoubiquitination after 48 hours of APH compared to the 24-hour
APH sample and the release samples shows that monoubiquitination has decreased
(Fig. 11b). We saw an increase in the protein expression in SOX5 following APH
treatment in the immunoblots as can be seen by comparing the 24-, 48-, and 24-hour
release samples to the no treatment sample (Fig. 11b). Tubulin was used a loading
control. Protein bands were further analyzed using ImageJ to measure protein band
intensities and band intensity was averaged across replicates (Fig. 11c). It can be seen
in the fold change of protein expression graph that there was an increase in the band
intensity further concluding that there was an increase in protein expression of SOX5
following the APH treatment (Fig. 11c). Standard deviations can also be seen on the
fold change expression graph displaying replicates with similar expression levels.
Bonferroni correction was applied by dividing 0.05 by the number of replicates tested
(3).
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Figure 11. Effect of aphidicolin on SOX5 protein expression. a. Cartoon of
experimental design. U2OS 3xFLAG cells were incubated in the absence (No
Treatment; NT) or presence of 0.4 µM APH for 24 hours, 48 hours, or 24 hours
plus 24 hours of release. b. The abundance of SOX5 and FANCD2 proteins
present in whole-cell lysates was determined by immunoblot using anti-SOX5
and anti-FANCD2 antibodies. Tubulin, detected with an anti-Tubulin antibody,
serves as a loading control. c. Protein band intensities analyzed using ImageJ and
statistical significance was determined using student’s two-tailed paired t-test. *P
< 0.01 and Single Factor ANOVA. Bonferroni correction has been applied.
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Analysis of protein expression of WWOX following aphidicolin exposure
We also analyzed the protein expression of WWOX following APH treatment and
determined that there was no difference between the no treatment condition and the
aphidicolin treated (Fig. 12b). The band intensity of the 24-, 48-, and 24-hour APH
release samples look the same as the no treatment sample (Fig. 12b). Further analysis
of the band intensity was again done by use of ImageJ quantification. It can be seen
that there is minor increase in the protein expression in the treated samples (Fig. 12c).
The standard errors are also shown on the fold change expression graph and display
replicates with similar expression levels. Bonferroni correction was applied by
dividing 0.05 by the number of replicates (3).
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Figure 12. Effect of aphidicolin on WWOX protein expression. a.
Cartoon of experimental design. U2OS 3xFLAG cells were plated at 1
million cells/mL and incubated in the absence (No Treatment; NT) or
presence of 0.4 µM APH for 24 hours, 48 hours, or 24 hours plus 24
hours of release. b. The abundance of WWOX and FANCD2 proteins
present in whole-cell lysates was determined by immunoblot using antiWWOX and anti-FANCD2 antibodies. Tubulin, detected with an antiTubulin antibody, serves as a loading control. c. Protein band intensities
analyzed using ImageJ. *P < 0.01 and Single Factor ANOVA.
Bonferroni correction has been applied.
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Analysis of the impact/effect of loss of FANCD2 on SOX5 protein expression
We then wanted to determine what the consequences of the loss of FANCD2 would
have on SOX5 protein expression following aphidicolin treatment. We treated U2OS
3xFLAG cells with an siFANCD2 and an siControl for 24 hours followed by 0.4 µM
APH treatment (Fig. 13a). In comparison to the siControl samples, there are no bands
in the lanes treated with the siFANCD2 (Fig. 13a). Results of the siControl bands
reveal that there is an increase in protein band intensity in the 48-hour and release
samples in comparison to the no treatment sample (Fig. 13b). In samples treated with
an siFANCD2, there is a minor decrease in protein levels in the 24-hour and release
sample lanes in comparison to the siFANCD2 no treatment lane (Fig. 13b). There does
not appear to be a change in expression levels when comparing the siFANCD2 48hour sample to the siFANCD2 no treatment sample (Fig. 13b). Changes in expression
levels were confirmed using ImageJ again to quantify the intensity of the protein
bands showing the decrease in siFANCD2 samples and increase in siControl samples
(Fig. 13c). The standard deviations can also be seen on the fold expression protein
level graph and show that replicates had similar expression levels for each of the
samples tested. Bonferroni correction was applied by dividing 0.05 by the number of
replicates tested (3).
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Figure 13. Effects on SOX5 after siRNA knockdown of FANCD2. a.
Cartoon of siRNA experimental design. U2OS 3xFLAG cells were plated at
175,000 cells/mL and treated with either an siControl or siFANCD2 for 24
hours. On Day 4 U2OS were incubated in the absence (No Treatment; NT) or
presence of 0.4 µM APH for 24 hours, 48 hours, or 24 hours plus 24 hours of
release. b. The abundance of SOX5 and FANCD2 proteins present in wholecell lysates was determined by immunoblot using anti-SOX5 and antiFANCD2 antibodies. Tubulin, detected with an anti-Tubulin antibody, serves as
a loading control. c. Protein band intensities analyzed using ImageJ with
siControl shown in blue and siFANCD2 shown in orange. Protein band
intensities analyzed using ImageJ. *P < 0.01 and Two-Factor ANOVA.
Bonferroni correction has been applied.
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Analysis of the impact/effect of loss of FANCD2 on WWOX protein expression
The same siRNA treatment was also performed to test WWOX using the same
siFANCD2 and siControl and using whole cell extracts looking at protein expression
via immunoblotting (Fig. 14a). In contrast to SOX5, western blots displaying WWOX
do not show an increase or decrease in protein level expression in the siControl lanes
or the siFANCD2 lanes except for the release sample in the siFANCD2 western lanes
(Fig. 14b). There does seem to be an increase in expression level when comparing the
siFANCD2 release sample to the siFANCD2 no treatment sample.
ImageJ analysis of band intensities display a slight reduction in the expression
of WWOX protein in the absence of FANCD2 as well as in the siControl samples, but
it is very minor (Fig. 14c). For both the siControl and siFANCD2 samples, they
increase initially from the no treatment to the 24-hour APH treatment and then
decrease back down to the same level as the no treatment sample. Standard deviations
also show that replicates were similar (Fig. 14b). Bonferroni correction was applied by
dividing 0.05 by the number of replicates tested (3).
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Figure 14. Effects on WWOX after siRNA knockdown of FANCD2. a.
Cartoon of siRNA experimental design. U2OS 3xFLAG cells were plated at
175,000 cells/mL and treated with either an siControl or siFANCD2 for 24
hours. On Day 4 U2OS were incubated in the absence (No Treatment; NT)
or presence of 0.4 µM APH for 24 hours, 48 hours, or 24 hours plus 24
hours of release. b. The abundance of SOX5 and FANCD2 proteins present
in whole-cell lysates was determined by immunoblot using anti-SOX5 and
anti-FANCD2 antibodies. Tubulin, detected with an anti-Tubulin antibody,
serves as a loading control. c. Protein band intensities analyzed using ImageJ
with siControl shown in blue and siFANCD2 shown in orange. *P < 0.01
and Two-Factor ANOVA. Bonferroni correction has been applied.
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Analysis of the impact/effect of loss of FANCD2 on SOX5 gene expression
Following the analysis of protein expression of SOX5 following an siFANCD2
treatment and APH treatment, we wanted to observe if there were transcript changes to
SOX5. Samples were run in triplicate and three biological samples were tested and
averaged with GAPDH used as the control housekeeping gene. In the absence of
FANCD2, there is an increase initially in the no treatment sample compared to the
siControl no treatment sample. After 24 hours of APH treatment, there is an increase
in the transcript levels for both the siControl and siFANCD2 samples. In the 48-hour
samples, there is a decrease in the siControl in comparison to the 24-hour sample and
is at the same level as the no treatment sample. siFANCD2 at 48 hours also decreases
compared to the 24-hour and again at the same level as the no treatment sample (Fig.
15). Both siControl and siFANCD2 displayed an increase in transcript levels in the 24hour release samples compared to the no treatment (Fig. 15). Significant differences
were seen between the siControl no treatment and siFANCD2 no treatment (Fig. 15).
Bonferroni correction was applied by dividing 0.05 by the number of replicates tested
(12).
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Figure 15. Analysis of SOX5 gene expression in U2OS cells
incubated in the absence or presence of aphidicolin (APH). U2OS
cells were incubated in the absence (No Treatment) or presence of 0.4
µM APH for 24 hours, 48 hours, or 24 hours plus 24 hours of release.
Cells were also treated with either an siControl (blue bars) or an
siFANCD2 (orange bars). Error bars represent the standard errors of the
mean calculated from twenty-seven technical replicate measurements
from three independent biological replicate experiments. Statistical
significance was determined using student’s two-tailed paired t-test. *, P
< 0.004. Bonferroni correction has been applied.
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Analysis of the impact/effect of loss of FANCD2 on WWOX gene expression
Again, following the analysis of protein expression of WWOX in the presence of an
siFANCD2 treatment and APH treatment, we wanted to observe if there were
transcript changes to WWOX. Samples were again run in triplicate and three biological
samples were tested and averaged with GAPDH used as the control housekeeping
gene. In the absence of FANCD2, there is an increase initially in the no treatment
sample compared to the siControl no treatment sample. Post 24 hours of APH
treatment, there is an increase in the transcript levels for the siControl sample,
however the siFANCD2 sample has stayed level with the no treatment sample. In the
48-hour samples, there are decreases in the both the siControl and siFANCD2 samples
compared to the 24-hour and no treatment samples (Fig. 16). Both siControl and
siFANCD2 displayed an increase in transcript levels in the 24-hour release samples
compared to the untreated samples (Fig. 16). A significant difference was seen
between the siControl no treatment and the siFANCD2 no treatment. Bonferroni
correction was applied by dividing 0.05 by the number of replicates tested replicates
(12).

53

siControl

3.0

Fold Change of Gene
Expression

siFANCD2

*

2.5
2.0
1.5
1.0
0.5

24

48

On 24/Off 24

(h)

APH 0.4 µM

No

Tr
ea

tm
en

t

0.0

Figure 16. Analysis of WWOX gene expression in U2OS cells
incubated in the absence or presence of aphidicolin (APH). U2OS
cells were incubated in the absence (No Treatment) or presence of 0.4
µM APH for 24 hours, 48 hours, or 24 hours plus 24 hours of release.
Cells were also treated with either an siControl (blue bars) or an
siFANCD2 (orange bars). Error bars represent the standard errors of the
mean calculated from twenty-seven technical replicate measurements
from three independent biological replicate experiments. Statistical
significance was determined using student’s two-tailed paired t-test. *, P
< 0.004. Bonferroni correction has been applied.
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RNA sequencing analysis of ACHT hTERT FANCG (FANCD2 -/-) and ACHT
hTERT FANCD2 reveal no levels of SOX5 and low levels of WWOX
As previously stated, FANCD2 was found to bind to and traverse large actively
transcribed genes in U2OS 3xFLAG cells under conditions of replication stress.
However, we wanted to see the effects of treatment with aphidicolin on telomerase
immortalized cells lacking FANCD2 as well as telomerase immortalized cells with
FANCD2 complemented back into the cell. A different cell line was chosen as ACHT
hTERT cells are human FA-D2 (FANCD2-/-) telomerase-immortalized skin fibroblast
cells with one cell line having FANCD2 complemented into the cell. By utilizing a
patient cell line, we are able to test and observe the effects that may be more
realistically occurring within the cells of FA patients.
ACHT FANCG (FANCD2-/-) cells were treated with 0.4 µM aphidicolin for
24 and 48 hours, harvested and sent to Genewiz for RNA sequencing analysis at 150
bp paired end sequencing at 60 million reads per sample. The analysis looked at read
counts which are the number of times a read maps to a specific gene. SOX5 was not
found to be expressed in the dataset and WWOX had similar read counts between cells
with FANCD2 and cells without FANCD2 but the difference in read counts was not
significant (Fig. 17).
Independent of SOX5 and WWOX, the RNA-seq dataset allowed us to analyze
the levels of expression of all FANCD2 targets identified by ChIP-seq. In the ChIPseq dataset generated by Okamoto et al., FANCD2 was found to bind to approximately
120 genes under conditions of replication stress. Therefore, we asked the question of if
there was a difference in the levels of expression of any of these genes in the absence
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or presence of FANCD2 and in the absence or presence of replication stress. Using the
differential analysis datasets for the no treatment samples, provided from Genewiz, it
was found that 79 of the 120 ChIP-seq genes were expressed in the RNA-seq data. In
the 24-hour APH samples 66 of the 120 ChIP-seq genes were expressed. Of the 79
genes found to overlap, 26 were found to be differentially expressed with 7 being
downregulated and 19 being upregulated (Table 7). In this data, upregulated refers to
an increase in ACHT hTERT FANCD2’s and downregulated refers to an increase in
ACHT hTERT FANCG’s. In the 24-hour APH treated samples, 22 of the 66
overlapping genes were found to be differentially expressed with 7 being
downregulated and 15 being upregulated (Table 8). Interestingly, 7 of the 26 genes
found in the no treatment samples and 6 of the 22 genes found in the 24-hour APH
treated samples are found to be related to autism, neurodevelopmental, psychiatric
disorders.
The RNA-seq data also allowed us to observe if there were differences in gene
ontology. Genewiz also provided a gene ontology analysis which categorized the gene
ontology and enrichment of gene ontology. It was found that the 5th most significantly
enriched gene sets in the 24-hour APH treated samples were nervous system
development (Fig. 21).
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Figure 17. RNA-seq analysis reveals no significant differential
expression in WWOX. Differential expression analysis displays the
number of reads found per gene and if there is a significant difference
between the ACHT hTERT +FANCD2 cells and the ACHT hTERT
+FANCG (FANCD2 -/-) cells. Cells were incubated in the absence (no
treatment) or presence of 0.4 µM APH. Normalized reads were averaged
between the 4 replicates for both cell lines and the standard deviation
was also calculated. In both conditions, SOX5 did not exhibit differential
expression.
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Gene Name log2FoldChange
TENM4*
-2.36
FAM155A
-0.87
NLGN1*
-0.76
PPP1CC
-0.75
SRSF3
-0.65
ASTN2*
-0.61
FARS2
-0.60
FRMD8
0.55
GPC6
0.56
PTPRM
0.63
NEGR1*
0.69
KIRREL3*
0.72
BTBD9
0.74
FHIT
1.01
SMYD3
1.17
ANKS1B
1.41
SPOCK1
1.43
NTM
1.71
FGF12
1.71
LMCD1
1.79
CDH4
2.42
PLCB1*
2.53
NCAM2*
2.94
PAPPA2
4.52
CTNND2
7.59
PTPRD
9.44

P-value
2.34E-15
7.24E-07
2.71E-10
5.68E-04
4.56E-03
3.84E-04
1.73E-03
2.98E-05
2.74E-04
1.86E-02
2.98E-05
2.00E-03
3.80E-06
3.50E-02
4.37E-08
2.50E-02
8.51E-25
7.75E-11
1.65E-03
2.46E-22
3.62E-06
4.38E-15
5.40E-46
4.69E-27
4.07E-12
2.24E-19

Table 7. RNA sequencing heat map of no treatment samples. Of the top 120 genes
from the Okamoto et al., 2018 ChIP-seq data, we observed that 27 genes from our
RNA seq analysis using ACHT hTERT +FANCD2 and ACHT hTERT +FANCG
were found to have log2foldchanges either <-0.5 or >0.5 and a P-value <0.05. Genes
with (*) are related with autism, neurodevelopmental or psychiatric disorders.
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Gene Name
TENM4*
FAM155A
LARGE1
FAT3
MDGA1*
MAGI2
AFF2
GPC6
LSAMP*
INPP4B
THSD7B
PRKN
SPOCK1
NEGR1*
SMYD3
CDH4
ANKS1B
NCAM2*
PLCB1*
FGF12
PAPPA2
PTPRD

log2FoldChange
-3.19
-0.98
-0.86
-0.71
-0.57
-0.55
-0.53
0.68
0.76
0.84
0.89
0.97
0.99
1.03
1.32
1.41
2.64
2.81
3.27
3.84
4.17
7.99

P-value
3.31E-56
8.66E-24
1.49E-26
4.84E-08
4.53E-08
2.91E-08
7.74E-05
3.18E-15
1.80E-11
1.38E-17
6.53E-03
1.57E-02
1.54E-68
1.73E-20
2.68E-23
2.00E-05
6.75E-07
3.27E-95
1.51E-31
8.69E-07
3.13E-11
4.41E-21

Table 8. RNA sequencing heat map of 24 h APH samples. Of the top 120 genes
from the Okamoto et al., 2018 ChIP-seq data, we observed that 17 genes from our
RNA seq analysis using ACHT hTERT +FANCD2 and ACHT hTERT +FANCG
were found to have log2foldchanges either <-0.5 or >0.5 and a P-value <0.05. Genes
with (*) are related with autism, neurodevelopmental or psychiatric disorders.
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CHAPTER 4

DISCUSSION

The protection and tight regulation of our genome is dependent upon the
coordination of several DNA repair pathways, including the FA pathway, to ensure the
timely repair of DNA damage. FANCD2, one of the key proteins in the FA pathway,
has recently been seen to bind to and traverse large actively transcribed genes under
conditions of replication stress (Okamoto et al., 2018). We sought to answer the
question of why is FANCD2 binding to these genes and if by doing so it has another
role in addition to the FA pathway as a potential regulator of transcription.
We used a candidate gene approach targeting SOX5 and WWOX which are
found in the top 10 genes FANCD2 was seen to bind to in the Okamoto ChIP-seq
dataset (Okamoto et al., 2018). SOX5 was chosen as it is a transcription factor that has
been seen to be involved in breast cancer regulation by the transactivation of EZH2
(Sun et al., 2019). It is also involved in the regulation of embryonic development as
well as the determination of cell fate (Pei et al., 2014). Choosing a gene involved in
breast cancer regulation is relevant as the FA pathway primarily monitors and repairs
sites of DNA damage that could otherwise lead to the development of bone marrow
failure, leukemia, or premature cancers (Alter et al., 2018). WWOX was also chosen as
it is a member of short-chain dehydrogenases and found to span the common fragile
site FRA16D (Driouch et al., 2002). It has also been seen that WWOX may play a role
in the DNA damage response as a modulator of the DNA damage checkpoint kinase
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ATM. Common fragile sites have an increased risk of being preferential targets of
genomic instability such as chromosomal breaks in response to replicative stress (AbuOdeh et al., 2014)
In this study, we observed that there is an increase in the protein levels of
SOX5 under conditions of replication stress and that this increase is significant in the
24-hour APH treatment compared to the no treatment sample. We also did test to see
if there was a difference in a 24-hour no treatment sample and 48-hour no treatment
sample for both SOX5 and WWOX and did not see differences in the protein levels
(Fig. 18). However, using qPCR to analyze the transcript levels of SOX5, we did not
see a significant difference when comparing the APH treated samples to the no
treatment control sample. There was also little change in WWOX both in protein and
transcript levels while FANCD2 was present and under the same conditions of
replication stress using APH. It was also found that to observe transcript levels, a large
quantity of cDNA (500 ng/µL) was needed for qPCR to observe crossing points that
were within the accepted analysis range. A possible reason for the limited changes in
the protein levels and overall low abundance of gene expression could be that these
two genes are just lowly expressed, and the proteins are very stable in U2OS 3xFLAG
cells. It could also be that the proteins for these genes are very stable and therefore the
mRNA is not always needed/necessary, so it is in low abundance. It should also be
noted that there is the possibility that these genes are so big and as seen in the
Okamoto et al., 2018 paper that it can take multiple cell cycles for these genes to be
transcribed, potentially causing replication-transcription conflicts. It would be
interesting to observe the half-life of the protein for both WWOX and SOX5 to
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determine how long each of these can be seen in a cell. If they can be seen for a longer
duration of time, it would support the idea that both proteins are stable and therefore
less mRNA would be needed.
Further analysis using an siFANCD2 to knockdown FANCD2 expression in
U2OS 3xFLAG cells as well as aphidicolin treatment, resulted in no difference in
protein expression levels regardless of FANCD2 presence for WWOX. This
experiment was performed to determine the impact the absence of FANCD2 could
have had on both SOX5 and WWOX genes and proteins. Protein expression for SOX5
was seen to increase under APH conditions in the presence of FANCD2 while without
FANCD2, there was slight decrease in the recovery sample, but the decrease was not
significant. Interestingly, our experiments indicate that both SOX5 and WWOX
transcript levels are increased in the absence of the FANCD2 protein. These results
suggest that in the absence of FANCD2, WWOX and SOX5 transcript levels are
increasing suggesting that FANCD2 may be monitoring their transcription and without
it, the genes are less controlled. If the transcription of WWOX and SOX5 is less
controlled, they could be transcribed even when they are not necessarily needed. As
these genes are prone to CNVs and WWOX overlaps with FRA16D, the uncontrolled
transcription of them could lead to an increase in genome instability and more
susceptibility to cancer.
As the differences seen in our results are minor, with some of the differences
not being significant, it brought us to the question of is FANCD2 regulating
transcription and if not, what is it doing at these two gene sites? It could be that
FANCD2 is regulating replication instead of transcription and helps in the stabilization
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of the DNA at sites that are more prone to DNA damage. It has been previously seen
that in the absence of FANCD2, replication forks stall within the AT-rich fragility
core of the FRA16D CFS and this can lead to the dormant origin activation
(Madireddy et al., 2016). It has also been previously seen that under conditions of
replication stress, FANCD2 is able to promote DNA replication (Lossaint et al., 2013).
It has also been seen that FANCD2 may play a role in the regulation of Rloops. R-loops, which are DNA: RNA hybrids are hazards to the genome and can
increase the probability of disruption of chromatin organization. The displaced ssDNA
in R-loops also poses a threat to the stability of the genome as ssDNA is more prone to
attracting nucleases (Sollier & Cimprich, 2015). However, R-loops can also be nonhazardous in the genome as they are required for immunoglobulin class switching
(García-Muse & Aguilera, 2016). Previously, Okamoto et al., 2018 also saw that
FANCD2 accumulates at large transcribed genes and that its accumulation may
depend on the formation of R-loops which can be induced by transcription-replication
collisions during mild replication stress. It would be interesting to determine if
FANCD2 is proximal to where these events are occurring and comparing the same
areas in the absence of FANCD2 under mild replication stress.
To study the role of FANCD2 in transcriptional regulation at a genome-wide
level, we also performed RNA-seq analysis using ACHT hTERT FANCD2 and
ACHT hTERT FANCG (FANCD2-/-) cells. We chose to use these cells because they
are FA patient-derived skin fibroblasts unlike U2OS cells, which are derived from an
osteosarcoma. ACHT cells therefore more closely resemble those of an FA patient.
Using RNA sequencing we were able to analyze not only SOX5 and WWOX but also
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the other 120 top gene hits from the Okamoto et al., paper. We observed that SOX5
was not expressed, and a small expression of WWOX was seen but with no significant
difference with/without the presence of FANCD2 (Fig. 17).
Upon further analysis of our RNA sequencing data, we found that of the 120
genes in the Okamoto et al., 2018 data set, 79 of the ChIP-seq genes were expressed in
the RNA-seq data in the no treatment sample and 66 genes in the 24-hour APH treated
samples. Of those 79 genes found to overlap, 26 genes were found to have log2fold
changes less than -0.05 or greater than 0.05 in the no treatment sample and 22 in the
24-hour APH treated samples (Tables 7 & 8). Of the 26 genes we also saw that 7 were
downregulated meaning that there is an increase in the ACHT hTERT FANCG’s and
19 were upregulated meaning that there is an increase in the ACHT hTERT FANCD2
samples (Table 9). In the APH treated samples, it was found that 7 genes were being
downregulated and 15 were upregulated (Table 10). Interestingly, 7 of the 26 in the no
treatment samples and 6 of the 22 genes found in the APH treated samples are found
to be related to autism, neurodevelopmental, psychiatric disorders. These findings and
differences seen in the RNA sequencing data support the notion that FANCD2 could
be playing a role in the transcriptional regulation of some genes.
Furthermore, it was found that a portion of the significantly differentially expressed
genes are related to nervous system development or nervous system conditions,
therefore suggesting that FANCD2 could also be contributing to the regulation of
neuronal derived genes.
We also input the genes found to have significant differences in gene
expression into the STRING database to determine their relationship to one another
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for both the no treatment samples and the APH treated samples (Figs. 19 & 20). If
there is a line between nodes, this indicates that there is an interaction between the
proteins. If there is no line, there is no interaction. The color of the line also represents
different associations with blue being that it is a known interaction from a curated
database, pink is experimentally determined, green is a gene neighborhood, red is gene
fusions, blue is gene co-occurrence, yellow is textmining, black is co-expression, and
purple is protein homology. Many of the proteins displaying an interaction are
associated with neuronal development such as the link between CTNND2, PTPRD,
ASTN2, and NLGN1 in the no treatment samples as seen in Fig. 18. All four of these
proteins play a role in neuronal development. Looking at the 24-hour APH samples it
can also be seen that there is a link between LSAMP, NEGR1, and MDGA1 which are
also related to neuronal functions (Fig. 20).
This analysis using the STRING database and our RNA sequencing data
reveals that there are proteins that have a significant difference in gene expression
between ACHT hTERT +FANCD2 and ACHT hTERT +FANCG samples that are
directly linked to neurological development functions. The STRING database is able
to integrate all known and predicted associations between proteins including but
physical and functional interactions. This is interesting because it further proposes the
possibility that FANCD2 has another role distinct from ICL repair in the FA pathway
and that the role could involve regulating neuronal development.
It was also observed that among the top differentially expressed genes
clustered by gene ontology, nervous system development was seen as the 5th most
differentially expressed under 24 hours of APH treatment (Fig. 21). The gene ontology
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analysis aims to identify the biological processes, cellular locations, and molecular
functions that have been impacted in the condition studied. This analysis is able to
reduce the complexity and instead highlight the biological processes in the genomewide expression studied. Identifying nervous system development as one of the
systems affected in this study which utilized two cell lines with one lacking FANCD2
additionally supports a hypothesis of FANCD2 assisting with neuronal development
and having another purpose apart from the FA pathway.

Future Experiments
We have made significant progress determining the consequences of replication stress
in the presence and absence of FANCD2 for WWOX and SOX5 and if FANCD2
could be involved in the transcriptional regulation of these two genes. However, these
were only two of the 120 genes that FANCD2 was found to bind to in the ChIP-seq
data (Okamoto et al., 2018). Here, we will propose several experiments to further
answer our question of why FANCD2 is binding and traversing large actively
transcribed genes under replication stress conditions.
We would further like to determine whether FANCD2 is also involved in the
regulation of R-loops as these as previously stated, also pose a threat to genomic
stability. The S9.6 antibody can be used to detect the presence of R-loops and it has
been previously seen that the members of the FA pathway (BRCA2/FANCD1)
accumulate at R-loops (García-Rubio et al., 2015). Since the FA pathway is involved
in the repair of interstrand crosslinks which block replication fork progression, this
suggests that because R-loops can also block replication progression, that these R-
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loops may be a contributor to genomic instability in FA cells (Schwab et al., 2015).
Schwab et al., 2015 also found that in cells with downregulated FANCD2, there was a
significant increase in asymmetric sister forks compared to their control cells which
suggests that that there is a deviation from the normal replication program. This also
suggests that FANCD2 may play a role in the regulation of replication. A previous
study also found that in cells deficient in FANCD2 and FANCA, there was an increase
in the number of R-loops suggesting that these two proteins play a role in R-loop
regulation (García-Rubio et al., 2015). It has also been previously found that the
FANCD2: FANCI heterodimer (ID2) preferentially binds ssRNA but not RNA: DNA
hybrids making it seem as though ID2 binds to the ssRNA that is displaced in R-loops
(Liang et al., 2019).
We would also like to further investigate other genes, separate from the
Okamoto dataset, that are found in our RNA sequencing data and have normalized
read counts that are significantly different. In the no treatment conditions, we have
examined the data and created a list of potential gene targets from different cell
pathways and families such as retinaldehyde dehydrogenases. Of the genes found to
have significant differences in normalized read counts in the RNA sequencing data,
we will perform western blots and qPCR on a subset of these genes to further confirm
the differences seen in the RNA sequencing data. We are also planning to perform
ChIP-seq on the ACHT hTERT +FANCD2 and ACHT hTERT +FANCG under APH
conditions to be able to compare to the U2OS 3xFLAG ChIP-seq data. This will be
important to be able to tell how different the two cell lines and determine if the genes
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that FANCD2 was found to bind to in the U2OS 3xFLAG cells are similar or different
in ACHTs.
We would also like to use a neurological stem cell line and using our
siFANCD2, determine the consequences of the absence of FANCD2 on a number of
genes found in the RNA sequencing data. We found in our RNA sequencing data, that
the development of neurological systems was found to be fifth in differentially
expressed gene ontology and of the 22 genes found to overlap with the ChIP
sequencing data and our RNA sequencing data under APH conditions, 6 of the 22
gene were found to be related with autism, neurodevelopmental, or psychiatric
disorders (Table 8). Using the neurological stem cell line would help us understand
more of whether FANCD2 is an integral part in maintaining neurological functions.
We would use qPCR as well as western blotting to detect if there are differences with
or without the presence of FANCD2 as well as in the presence or absence of APH.
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Figure 18. U2OS 3xFLAG cells grown for either 24 hours or 48
hours with no treatment (NT) added. Abundance of SOX5 and
WWOX proteins present in whole-cell lysates was determined by
immunoblot using an anti-SOX5 and anti-WWOX antibodies. Tubulin,
detected with an anti-Tubulin antibody, serves as a loading control.
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Figure 19. RNA sequencing reveals potential link between FANCD2
and neurological development in no treatment samples. Cells were
harvested, flash frozen using liquid nitrogen and sent to Genewiz for
RNA sequencing analysis at 150 bp paired end sequencing at 60 million
reads per sample. Using the differential analysis datasets for the no
treatment samples provided from Genewiz, it was found that 26 of the
120 Okamoto et al., 2018 ChIP-seq genes FANCD2 was found to bind to
overlap with the RNA seq data for the no treatment samples. Of the 26
genes, 7 of them are found to be related with autism,
neurodevelopmental, or psychiatric disorders. The 26 genes were input
to STRING database to see if they connect to one another. The color of
the line also represents different associations with blue being that it is a
known interaction from a curated database, pink is experimentally
determined, green is a gene neighborhood, red is gene fusions, blue is
gene co-occurrence, yellow is textmining, black is co-expression, and
purple is protein homology.
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Figure 20. RNA sequencing reveals potential link between FANCD2
and neurological development in aphidicolin treated samples. Cells
were harvested, flash frozen using liquid nitrogen and sent to Genewiz
for RNA sequencing analysis at 150 bp paired end sequencing at 60
million reads per sample. Using the differential analysis datasets for the
24-hour APH samples provided from Genewiz, it was found that 22 of
the 120 Okamoto et al., 2018 ChIP-seq genes FANCD2 was found to
bind to overlap with the RNA seq data for the no treatment samples. Of
the 22 genes, 6 of them are found to be related with autism,
neurodevelopmental, or psychiatric disorders. The 22 genes were input
to STRING database to observe the relationship between one another.
The color of the line also represents different associations with blue
being that it is a known interaction from a curated database, pink is
experimentally determined, green is a gene neighborhood, red is gene
fusions, blue is gene co-occurrence, yellow is textmining, black is coexpression, and purple is protein homology.
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Figure 21. RNA-seq data displaying 24-hour aphidicolin (APH)
differentially expressed genes categorized by gene ontology. ACHT
hTERT FANCG (FANCD2 -/-) cells and ACHT hTERT FANCD2 were
incubated in the absence or presence of 0.4 µM aphidicolin (APH) for
24 and 48 hours in T-75 flasks. Cells were harvested, flash frozen using
liquid nitrogen and sent to Genewiz for RNA sequencing analysis at 150
bp paired end sequencing at 60 million reads per sample. Genewiz
analysis provided a differentially expressed genes by gene ontology
th
table in which it was found that the 5 most differentially expressed was
nervous system development in the 24-hour APH samples.

72

BIBLIOGRAPHY

Abu-Odeh, M., Salah, Z., Herbel, C., Hofmann, T. G., & Aqeilan, R. I. (2014). WWOX,
the common fragile site FRA16D gene product, regulates ATM activation and the
DNA damage response. Proceedings of the National Academy of Sciences of the
United States of America, 111(44), E4716–E4725.
https://doi.org/10.1073/pnas.1409252111
Alter, B. P., Giri, N., Savage, S. A., & Rosenberg, P. S. (2018). Cancer in the national
cancer institute inherited bone marrow failure syndrome cohort after fifteen years of
follow-up. Haematologica, 103(1), 30–39.
https://doi.org/10.3324/haematol.2017.178111
Barlow, J. H., Faryabi, R. B., Callén, E., Wong, N., Malhowski, A., Chen, H. T., GutierrezCruz, G., Sun, H. W., McKinnon, P., Wright, G., Casellas, R., Robbiani, D. F., Staudt,
L., Fernandez-Capetillo, O., & Nussenzweig, A. (2013). Identification of early
replicating fragile sites that contribute to genome instability. Cell, 152(3), 620–632.
https://doi.org/10.1016/j.cell.2013.01.006
Byun, T. S., Pacek, M., Yee, M. C., Walter, J. C., & Cimprich, K. A. (2005). Functional
uncoupling of MCM helicase and DNA polymerase activities activates the ATRdependent checkpoint. Genes & development, 19(9), 1040–1052.
https://doi.org/10.1101/gad.1301205
Chan, K. L., Palmai-Pallag, T., Ying, S., & Hickson, I. D. (2009). Replication stress
induces sister-chromatid bridging at fragile site loci in mitosis. Nature Cell Biology,
11(6), 753–760. https://doi.org/10.1038/ncb1882

73

Debatisse, M., le Tallec, B., Letessier, A., Dutrillaux, B., & Brison, O. (2012). Common
fragile sites: Mechanisms of instability revisited. In Trends in Genetics (Vol. 28, Issue
1, pp. 22–32). Trends Genet. https://doi.org/10.1016/j.tig.2011.10.003
Driouch, K., Prydz, H., Monese, R., Johansen, H., Lidereau, R., & Frengen, E. (2002).
Alternative transcripts of the candidate tumor suppressor gene, WWOX, are expressed
at high levels in human breast tumors. Oncogene, 21(12), 1832–1840.
https://doi.org/10.1038/sj.onc.1205273
Feng, G., Yuan, Y., Li, Z., Wang, L., Zhang, B., Luo, J., Ji, J., & Kong, D. (2019).
Replication fork stalling elicits chromatin compaction for the stability of stalling
replication forks. Proceedings of the National Academy of Sciences of the United
States of America, 116(29), 14563–14572. https://doi.org/10.1073/pnas.1821475116
Fernandes, P., Miotto, B., Saint-Ruf, C., Said, M., Barra, V., Nähse, V., Ravera, S.,
Cappelli, E., & Naim, V. (2021). FANCD2 modulates the mitochondrial stress
response to prevent common fragile site instability. Communications biology, 4(1),
127. https://doi.org/10.1038/s42003-021-01647-8
Fiesco-Roa, M. O., Giri, N., McReynolds, L. J., Best, A. F., & Alter, B. P. (2019).
Genotype-phenotype associations in Fanconi anemia: A literature review. In Blood
Reviews (Vol. 37, p. 100589). Churchill Livingstone.
https://doi.org/10.1016/j.blre.2019.100589
Garcia-Higuera, I., Taniguchi, T., Ganesan, S., Meyn, M. S., Timmers. C., Hejna, J.,
Grompe, M., & D’Andrea, A. D., (2001). Interaction of the Fanconi anemia proteins
and BRXA1 in a common pathway. Molecular cell, 7(2), 249-262.
https://doi.org/10.1016/s1097-2765(01)00173-3

74

García-Muse, T., & Aguilera, A. (2016). Transcription-replication conflicts: How they
occur and how they are resolved. In Nature Reviews Molecular Cell Biology (Vol. 17,
Issue 9, pp. 553–563). Nature Publishing Group. https://doi.org/10.1038/nrm.2016.88
García-Rubio, M. L., Pérez-Calero, C., Barroso, S. I., Tumini, E., Herrera-Moyano, E.,
Rosado, I. v., & Aguilera, A. (2015). The Fanconi Anemia Pathway Protects Genome
Integrity from R-loops. PLoS Genetics, 11(11), 1005674.
https://doi.org/10.1371/journal.pgen.1005674
Glover, T. W., Wilson, T. E., & Arlt, M. F. (2017). Fragile sites in cancer: More than meets
the eye. In Nature Reviews Cancer (Vol. 17, Issue 8, pp. 489–501). Nature Publishing
Group. https://doi.org/10.1038/nrc.2017.52
Hamperl, S., & Cimprich, K. A. (2016). Conflict Resolution in the Genome: How
Transcription and Replication Make It Work. In Cell (Vol. 167, Issue 6, pp. 1455–
1467). Cell Press. https://doi.org/10.1016/j.cell.2016.09.053
Hänsel-Hertsch, R., di Antonio, M., & Balasubramanian, S. (2017). DNA G-quadruplexes
in the human genome: Detection, functions and therapeutic potential. Nature Reviews
Molecular Cell Biology, 18(5), 279–284. https://doi.org/10.1038/nrm.2017.3
Hays, L., Frohnmayer, D., Frohnmayer, L., Larsen, K., & Owen, J. (2014). Fanconi
Anemia: Guidelines for Diagnosis and Management. Fanconi Anemia Research Fund,
Inc., 1–391. http://www.ncbi.nlm.nih.gov/books/NBK1401/
Helmrich, A., Ballarino, M., & Tora, L. (2011). Collisions between Replication and
Transcription Complexes Cause Common Fragile Site Instability at the Longest
Human Genes. Molecular Cell, 44(6), 966–977.
https://doi.org/10.1016/j.molcel.2011.10.013

75

Howlett, N. G., Taniguchi, T., Durkin, S. G., D’Andrea, A. D., & Glover, T. W. (2005).
The Fanconi anemia pathway is required for the DNA replication stress response and
for the regulation of common fragile site stability. Human Molecular Genetics, 14(5),
693–701. https://doi.org/10.1093/hmg/ddi065
Huang, Y., Leung, J. W. C., Lowery, M., Matsushita, N., Wang, Y., Shen, X., Huong, D.,
Takata, M., Chen, J., & Li, L. (2014). Modularized Functions of the Fanconi Anemia
Core Complex. Cell Reports, 7(6), 1849–1857.
https://doi.org/10.1016/j.celrep.2014.04.029
Joo, W., Xu, G., Persky, N. S., Smogorzewska, A., Rudge, D. G., Buzovetsky, O., Elledge,
S. J., & Pavletich, N. P. (2011). Structure of the FANCI-FANCD2 complex: Insights
into the Fanconi anemia DNA repair pathway. Science, 333(6040), 312–316.
https://doi.org/10.1126/science.1205805
Kalb, R., Neveling, K., Hoehn, H., Schneider, H., Linka, Y., Batish, S. D., Hunt, C.,
Berwick, M., Callen, E., Surralles, J., Casado, J. A., Bueren, J., Dasi, A., Soulier, J.,
Gluckman, E., Zwaan, C. M., van Spaendonk, R., Pals, G., de Winter, J. P., Joenje, H.,
Schindler, D. (2007). Hypomorphic mutations in the gene encoding a key Fanconi
anemia protein, FANCD2, sustain a significant group of FA-D2 patients with severe
phenotype. American journal of human genetics, 80(5), 895–910.
https://doi.org/10.1086/517616
Kee, Y., & D’Andrea, A. D. (2012). Molecular pathogenesis and clinical management of
Fanconi anemia. In Journal of Clinical Investigation (Vol. 122, Issue 11, pp. 3799–
3806). American Society for Clinical Investigation. https://doi.org/10.1172/JCI58321

76

Kim, H., & D’Andrea, A. D. (2012). Regulation of DNA cross-link repair by the Fanconi
anemia/BRCA pathway. In Genes and Development (Vol. 26, Issue 13, pp. 1393–
1408). Cold Spring Harbor Laboratory Press. https://doi.org/10.1101/gad.195248.112
Kim, Y., Lach, F. P., Desetty, R., Hanenberg, H., Auerbach, A. D., & Smogorzewska, A.
(2011). Mutations of the SLX4 gene in Fanconi anemia. In Nature Genetics (Vol. 43,
Issue 2, pp. 142–146). Nature Publishing Group. https://doi.org/10.1038/ng.750
Le Tallec, B., Koundrioukoff, S., Wilhelm, T., Letessier, A., Brison, O., & Debatisse, M.
(2014). Updating the mechanisms of common fragile site instability: how to reconcile
the different views? Cellular and molecular life sciences: CMLS, 71(23), 4489-4494.
https://doi.org/10.1007.s00018-01401720-2
Liang, Z., Liang, F., Teng, Y., Chen, X., Liu, J., Longerich, S., Rao, T., Green, A. M.,
Collins, N. B., Xiong, Y., Lan, L., Sung, P., & Kupfer, G. M. (2019). Binding of
FANCI-FANCD2 Complex to RNA and R-Loops Stimulates Robust FANCD2
Monoubiquitination. Cell Reports, 26(3), 564-572.e5.
https://doi.org/10.1016/j.celrep.2018.12.084
Lossaint, G., Larroque, M., Ribeyre, C., Bec, N., Larroque, C., Décaillet, C., Gari, K., &
Constantinou, A. (2013). FANCD2 binds MCM proteins and controls replisome
function upon activation of s phase checkpoint signaling. Molecular cell, 51(5), 678–
690. https://doi.org/10.1016/j.molcel.2013.07.023
Madireddy, A., Kosiyatrakul, S. T., Boisvert, R. A., Herrera-Moyano, E., García-Rubio, M.
L., Gerhardt, J., Vuono, E. A., Owen, N., Yan, Z., Olson, S., Aguilera, A., Howlett, N.
G., & Schildkraut, C. L. (2016). FANCD2 Facilitates Replication through Common

77

Fragile Sites. Molecular Cell, 64(2), 388–404.
https://doi.org/10.1016/j.molcel.2016.09.017
Maffia, A., Ranise, C., & Sabbioneda, S. (2020). From R-loops to G-quadruplexes:
Emerging new threats for the replication fork. In International Journal of Molecular
Sciences (Vol. 21, Issue 4). MDPI AG. https://doi.org/10.3390/ijms21041506
Magdalou, I., Lopez, B. S., Pasero, P., & Lambert, S. A. (2014). The causes of replication
stress and their consequences on genome stability and cell fate. Seminars in cell &
developmental biology, 30, 154-164. https://doi.org/10.1016/j.semcdb.2014.04.035
Mankouri, H. W., Huttner, D., & Hickson, I. D. (2013). How unfinished business from Sphase affects mitosis and beyond. In EMBO Journal (Vol. 32, Issue 20, pp. 2661–
2671). John Wiley & Sons, Ltd. https://doi.org/10.1038/emboj.2013.211
Milletti, G., Strocchio, L., Pagliara, D., Girardi, K., Carta, R., Mastronuzzi, A., Locatelli,
F., & Nazio, F. (2020). Canonical and noncanonical roles of fanconi anemia proteins:
Implications in cancer predisposition. In Cancers (Vol. 12, Issue 9, pp. 1–23). MDPI
AG. https://doi.org/10.3390/cancers12092684
Niraj, J., Färkkilä, A., & D’Andrea, A. D. (2019). The fanconi anemia pathway in cancer.
In Annual Review of Cancer Biology (Vol. 3, Issue 1, pp. 457–478). Annual Reviews
Inc. https://doi.org/10.1146/annurev-cancerbio-030617-050422
Okamoto, Y., Hejna, J., & Takata, M. (2019). Regulation of R-loops and genome instability
in Fanconi anemia. In Journal of Biochemistry (Vol. 165, Issue 6, pp. 465–470).
Oxford University Press. https://doi.org/10.1093/jb/mvz019
Okamoto, Y., Iwasaki, W. M., Kugou, K., Takahashi, K. K., Oda, A., Sato, K., Kobayashi,
W., Kawai, H., Sakasai, R., Takaori-Kondo, A., Yamamoto, T., Kanemaki, M. T.,

78

Taoka, M., Isobe, T., Kurumizaka, H., Innan, H., Ohta, K., Ishiai, M., & Takata, M.
(2018). Replication stress induces accumulation of FANCD2 at central region of large
fragile genes. Nucleic Acids Research, 46(6), 2932–2944.
https://doi.org/10.1093/nar/gky058
Pei, X. H., Lv, X. Q., & Li, H. X. (2014). Sox5 induces epithelial to mesenchymal
transition by transactivation of Twist1. Biochemical and Biophysical Research
Communications, 446(1), 322–327. https://doi.org/10.1016/j.bbrc.2014.02.109
Scheckenbach, K., Morgan, M., Filger-Brillinger, J., Sandmann, M., Strimling, B.,
Scheurlen, W., Schindler, D., Göbel, U., & Hanenberg, H. (2012). Treatment of the
bone marrow failure in Fanconi anemia patients with danazol. Blood cells, molecules
& diseases, 48(2), 128-131. https://doi.org/10.1016/j.bcmd.2011.11.006
Schlacher, K., Wu, H., & Jasin, M. (2012). A Distinct Replication Fork Protection Pathway
Connects Fanconi Anemia Tumor Suppressors to RAD51-BRCA1/2. Cancer Cell,
22(1), 106–116. https://doi.org/10.1016/j.ccr.2012.05.015
Schwab, R. A., Nieminuszczy, J., Shah, F., Langton, J., Lopez Martinez, D., Liang, C. C.,
Cohn, M. A., Gibbons, R. J., Deans, A. J., & Niedzwiedz, W. (2015). The Fanconi
Anemia Pathway Maintains Genome Stability by Coordinating Replication and
Transcription. Molecular cell, 60(3), 351-361.
https://doi.org/10.1016/j.molcel.2015.09.012
Shima, N., & Pederson, K. D. (2017). Dormant origins as a built-in safeguard in eukaryotic
DNA replication against genome instability and disease development. In DNA Repair
(Vol. 56, pp. 166–173). Elsevier B.V. https://doi.org/10.1016/j.dnarep.2017.06.019

79

Sollier, J., & Cimprich, K. A. (2015). Breaking bad: R-loops and genome integrity. In
Trends in Cell Biology (Vol. 25, Issue 9, pp. 514–522). Elsevier Ltd.
https://doi.org/10.1016/j.tcb.2015.05.003
Stoepker, C., Hain, K., Schuster, B., Hilhorst-Hofstee, Y., Rooimans, M. A., Steltenpool,
J., Oostra, A. B., Eirich, K., Korthof, E. T., Nieuwint, A. W. M., Jaspers, N. G. J.,
Bettecken, T., Joenje, H., Schindler, D., Rouse, J., & de Winter, J. P. (2011). SLX4, a
coordinator of structure-specific endonucleases, is mutated in a new Fanconi anemia
subtype. In Nature Genetics (Vol. 43, Issue 2, pp. 138–141). Nat Genet.
https://doi.org/10.1038/ng.751
Sun, C., Ban, Y., Wang, K., Sun, Y., & Zhao, Z. (2019). SOX5 promotes breast cancer
proliferation and invasion by transactivation of EZH2. Oncology Letters, 17, 27542762. https://doi.org/10.3892/ol.2019.9914
Tan, W., van Twest, S., Leis, A., Bythell-Douglas, R., Murphy, V. J., Sharp, M., Parker, M.
W., Crismani, W., & Deans, A. J. (2020). Monoubiquitination by the human Fanconi
anemia core complex clamps FANCI:FANCD2 on DNA in filamentous
arrays. eLife, 9, e54128. https://doi.org/10.7554/eLife.54128
Taniguchi, T., Garcia-Higuera, I., Andreassen, P.R., Gregory, R. C., Grompe, M., &
D’Andrea, A. D. (2002). S-phase-specific interaction of the Fanconi anemia protein,
FANCD2, with BRCA1 and RAD51. Blood, 100(7), 2414-2420.
https://doi.org/10.1182/blood-2002-01-0278
Wilson, T., E., Arlt, M. F., Park, S. H., Rajendran, S., Paulsen, M., Ljungman, M., &
Glover, T. W. (2015). Large transcription units unify copy number variants and

80

common fragile sites arising under replication stress. Genome research, 25(2), 189200. https://doi.org/10.1101/gr.177121.114
Zeman, M. K., & Cimprich, K. A. (2014). Causes and consequences of replication
stress. Nature cell biology, 16(1), 2–9. https://doi.org/10.1038/ncb2897

81

